Covered recipient · General Payments record
DEREK C LOU
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$22,588.56
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $323.73 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $96.31 | 1 |
| MERZ NORTH AMERICA, INC. | $58.38 | 2 |
| REVANCE THERAPEUTICS, INC. | $49.72 | 2 |
| ABBVIE INC. | $47.21 | 2 |
| TELA Bio, Inc. | $35.68 | 1 |
| Galderma Laboratories, L.P. | $19.11 | 1 |
| Acera Surgical, Inc. | $17.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.58 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104903440 | CMS |
| ABBVIE INC. | $13.63 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104903442 | CMS |
| Acera Surgical, Inc. | $17.32 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152414264 | CMS |
| Galderma Laboratories, L.P. | $19.11 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145313933 | CMS |
| Medtronic, Inc. | $96.31 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119395704 | CMS |
| MERZ NORTH AMERICA, INC. | $29.61 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146369215 | CMS |
| MERZ NORTH AMERICA, INC. | $28.77 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146369217 | CMS |
| REVANCE THERAPEUTICS, INC. | $20.16 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923370 | CMS |
| REVANCE THERAPEUTICS, INC. | $29.56 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923372 | CMS |
| TELA Bio, Inc. | $35.68 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154190286 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.